baber/WOPTO huggingface dataset:
Patent NZ-335952-A (NZ)
Title: Use of piperazinyl-heterocyclic compounds for treating glaucoma and ischemic retinopathy
Inventor: HOWARD HARRY RALPH
IPC: A61P27/02
Filed: 1999-05-25
Abstract: Compounds of formula (I) may be used to decrease intraocular pressure in a mammal or to treat glaucoma or ischemic retinopathy. In formula (I): Ar is benzoisothiazolyl or an oxide or dioxide thereof optionally substituted by fluoro, chloro, trifluoromethyl, methoxy, cyano, nitro, or naphthyl optionally substituted by fluoro, chloro, trifluoromethyl, methoxy, cyano or nitro; quinolyl; 6-hydroxy-8-quinolyl; isoquinolyl; quinazolyl; benzothiazolyl; benzothiadiazolyl; benzotriazolyl; benzoxazolyl; benzoxazolonyl; indolyl; indanyl optionally substituted by one or two fluoro, 3-indazolyl optionally substituted by 1-trifluoromethylphenyl; or phthalazinyl; n is 1 or 2 and X and Y together with the phenyl to which they are attached form a cyclic ring system selected from quinolyl; 2-hydroxyquinolyl; benzothiazolyl; 2-aminobenzothiazolyl; benzoisothiazolyl; indazolyl; 2-hydroxyindazolyl; indolyl; spirocycloalkyl oxindolyl, wherein said cycloalkyl moiety contains from 4 to 7 carbon atoms, optionally substituted by one to three of C1-C3 alkyl, or one of chloro, fluoro or phenyl optionally substituted by chloro or fluoro; benzoxazolyl; 2-aminobenzoxazolyl; benzoxalonyl; 2-aminobenzoxazolinyl; benzothiazolonyl, benzoimidazolonyl or benzotriazolyl. Particularly preferred compounds are ziprasidone mesylate trihydrate or ziprasidone hydrochloride monohydrate.
Patent NZ-500594-A (NZ)
Title: Submersible and retrievable buoy comprising at least two jaws, one of which forms part of hermetic seal and remote control thereof
Inventor: FIOTAKIS JOHN MICHAEL
IPC: B63B22/00
Filed: 1998-04-03
Abstract: Provided is an apparatus, more particular an aquatic buoy (5), which can be submerged and subsequently retrieved, comprising a body (4) having at least two jaws (28, 29), the jaws being configured to releasably retain a member (shackle pin 20 and a rope 6) and displacing means (an actuator, not shown, in sealed space 101) separated from member (20) by a hermetic seal (cap 16) formed on the body to confine the displacing means substantially within the body.  The displacing means is operable to move at least one of the jaws 28 to release and/or retain member 20.  At least one of the jaws forms part of the hermetic seal. The actuator may comprise a rod connected at one end thereof to movable jaw 28 and at the other end thereof to a motor and gear mechanism arranged to bias jaw 28 toward/away from the other jaw 29 to grasp/release the member to/from the body. The buoy may be fitted with a device to allow the actuator to be activated remotely via a transmitted signal to the buoy.
Patent NZ-502652-A (NZ)
Title: Method of microbial bioconversion of industrial or agricultural cellulose containing wastes
Inventor: LIZAK YURI
IPC: A23K1/00
Filed: 1998-09-10
Abstract: A process of conversion of low protein, cellulose-containing waste into a fodder or fodder supplement.  The process involves: a) inoculating the waste under aerobic conditions with a first inoculum including at least one first micro-organism capable of converting cellulose into carbohydrates and at least one second micro-organism capable of converting carbohydrates into protein, thereby converting cellulose into nutritional proteins and preventing the accumulation of carbohydrates and b) inoculating the waste under anaerobic conditions with a second inoculum including at least one third micro-organism capable of converting cellulose into carbohydrates and at least one fourth micro-organism capable of converting carbohydrates into a preservative organic acid. The anaerobic conditions are achieved by packaging the cellulose containing waste within a vacuum treated airtight bag.
Patent NZ-503670-A (NZ)
Title: Horizontal axis type wind turbine comprising a rotor supported by a nacelle mounted on a tower
Inventor: YOSHIDA SHIGEO
IPC: F03D11/04
Filed: 2000-03-30
Abstract: Provided for is a horizontal axis type wind turbine (1).  The turbine has a tower (11) mounted on a base (10), a nacelle  (21) mounted on the tower and a rotor (31) supported by the nacelle.  The tower is comprised of tower members (15), with the lower tower member  being mounted on the base tower member via a hinge for enabling the lower tower member to be laid horizontally on the ground and erected upright.
Patent NZ-510501-A (NZ)
Title: High purity composition comprising (7alpha,17beta)- 17- hydroxy- 7-methyl- 19-nor-17-pregn- 5(10)-en-20-yn-3-one
Inventor: KIRCHHOLTES PETER HUUB GERARD
IPC: C07J7/00
Filed: 1999-10-11
Abstract: A process for the preparation of a high purity composition of (7,17)- 17-hydroxy- 7-methyl- 19-nor-17-pregn- 5(10)-en-20-yn-3-one. The process provides for a composition with less than 0.5 % of (7,17)- 17-hydroxy- 7-methyl- 19-nor-17-pregn- 4-en-20-yn- 3-one. This composition can be used as a source for the preparation of stable pharmaceutical dosage units.
Patent NZ-510911-A (NZ)
Title: Garden refuse shredding apparatus
Inventor: REINHOLD THEODORE WILLIAM
IPC: B02C18/10
Filed: 1999-09-03
Abstract: A garden refuse shredding apparatus (10) which has a chipping rotor supported for rotation about a vertical shaft in a chamber (11) which has a hopper (14) which feeds refuse to radially disposed elongate chipper blades which span a major part of the rotor . Fan blades are supported on the rotor for creating an airflow through the hopper (14) to assist feed to the chipping rotor and to assist discharge of shredded refuse from the outlet . The chipping rotor (20) is driven directly from the vertical output shaft of an electric motor or a petrol engine (21).
Patent NZ-511725-A (NZ)
Title: Expandable MRI receiving coil having a second balloon disposed about a first balloon and having wire receiving grooves in the outer surface of the first balloon and in the inner surface of the second balloon
Inventor: MINKOFF LAWRENCE A
IPC: A61B5/055
Filed: 1999-11-18
Abstract: A magnetic resonance image receiving coil (10) includes a first balloon (12) having a longitudinal axis.  An internal surface of the first balloon (12) defines an internal inflatable chamber.  A second balloon (14) has a longitudinal axis.  The second balloon (14) is disposed about the first balloon (12).  A plurality of longitudinally extending grooves (16, 18, 20, 22) is disposed in one of an external surface of the first balloon (12), and the internal surface of the second balloon (14).  A first wire (28) is disposed in at least one of the grooves. A second wire (30) is disposed in at least a second one of the grooves (16, 20, 22).  Each of the first wire (28), and the second wire (30) is adapted to be electrically connected to an MRI apparatus.
Patent NZ-515645-A (NZ)
Title: Methods of purifying plasmid DNA mixture containing host cell impurities
Inventor: RAMASUBRAMANYAN NATARAJAN
IPC: C12N15/09
Filed: 2000-05-26
Abstract: Methods for the purification of plasmid DNA that includes removal of host cell impurities, such as endotoxins, RNA, proteins, and chromosomal DNA, from an aqueous solution containing plasmid DNA and methods for separation and purification of supercoiled plasmid DNA from an aqueous solution containing a mixture of supercoiled and nicked or relaxed plasmid DNA using hydrophobic interaction chromatography supports such as methacrylate polymer or copolymer backbone bound to a least one of a propyl, butyl, hexyl, octyl, nonyl or decyl pendent hydrophobic groups are disclosed.
Patent NZ-518788-A (NZ)
Title: Cleaning system utilizing an organic cleaning solvent and a pressurized fluid solvent
Inventor: RACETTE TIMOTHY L
IPC: D06F43/08
Filed: 2000-10-13
Abstract: A process for cleaning substrates comprises placing the substrates  to be cleaned in a cleaning vessel  wherein  the cleaning  vessel is not pressurized; adding organic  solvent to  the cleaning vessel wherein the organic fluid solvent is in  a  liquid  state  at or substantially  near  atmospheric pressure and room temperature; cleaning the substrates  with the  organic  solvent;  removing a portion  of  the  organic solvent from the cleaning vessel; placing the substrates  in a  drying  vessel; adding pressurized fluid solvent  to  the drying  vessel; removing the pressurized fluid solvent  from the  drying  vessel;  and removing the substrates  from  the drying  vessel.   The  pressurized  fluid  solvent  can   be densified carbon dioxide and the organic solvent  can  be  a glycol  ether or a poly glycol ether.  A system for cleaning textiles comprises a non-pressurized cleaning vessel adapted to  hold  contaminated  textiles  and  organic  solvent;  an organic  solvent tank operatively connected to the  cleaning vessel;  a pump for pumping organic solvent from the organic solvent tank to the cleaning vessel; a pressurizable  drying vessel  adapted  to hold cleaned substrates and  pressurized fluid  solvent; a carbon dioxide tank operatively  connected to  the  drying  vessel; and a pump for pumping  pressurized fluid  solvent  from the carbon dioxide tank to  the  drying vessel.
Patent NZ-520431-A (NZ)
Title: Lamp
Inventor: LOGA SIMONA
IPC: F21V9/40
Filed: 2001-02-06
Abstract: A lamp comprising a tubular gas discharge lamp (1) provided with at least one concave reflector (2) which, when viewed from the area to be illuminated, is arranged next to the lamp (1), and provided with at least one at least partially transparent diffuser (3) which, also when viewed from the area to be illuminated, is arranged next to the lamp (1), however, in front of the reflector (2). The diffuser (3) and the reflector (2) delimit, next to the lamp (1), at least one light entry surface and converge at their end located at a distance from the lamp (1). They converge such that they form at least one light chamber (4), whereby the ratio between the width (a) of a light chamber and the height (b) of the light entry surface is equal to at least 4: 1. In addition, means can be provided in order to obtain a uniform luminance over the width of the reflector.
Patent NZ-526083-A (NZ)
Title: Method for preparing tryptophan rich peptides
Inventor: MALLEE LEON FRANCISCUS
IPC: C07K14/47
Filed: 2000-12-06
Abstract: Described is a method for selectively isolating tryptophan containing peptides from an aqueous peptide mixture, comprising the steps of: a) controlling the pH of the aqueous peptide mixture to 4,0-6,0, forming a precipitate of tryptophan containing peptides; and b) isolation of the precipitated peptides. The aqueous peptide mixture is preferably obtained by enzymatic cleavage at acidic pH of a protein source. Further, peptides having a Trp content of 8-15 w/w% and the use thereof as food additive and as active ingredient in a medicament are described.
Patent NZ-527843-A (NZ)
Title: Method and apparatus for the preparation of triptane and/or triptene
Inventor: COOK STEVEN DAVID
IPC: C07C7/09
Filed: 2002-02-27
Abstract: A continuous or semi-continuous process for the production of triptane and/or triptene from methanol and/or dimethyl ether is disclosed wherein the reaction process is carried out in a reactor in the presence of an effective concentration of catalyst active for the conversion of methanol and/or dimethyl ether to triptane and/or triptene in which process co-produced water is separated from the catalyst as a vapour phase whilst the catalyst is retained in a liquid or solid phase. Preferably, the catalyst comprises zinc halide and is maintained in said reactor in an active form and an effective concentration. Apparatus for use in the process may comprise a reactor having at least one reaction zone and at least one separation zone.
Patent NZ-532601-A (NZ)
Title: A vacuum and rate control for a breastpump
Inventor: SILVER BRIAN H
IPC: A61M1/06
Filed: 2004-04-28
Abstract: A vacuum pump for a breast pump comprising a source of vacuum for applying a level of vacuum force; a motor drive for said source of vacuum; a mechanism which alters the level of vacuum force from said source of vacuum, and which varies a rate of vacuum application; a controller, said controller providing a rate control input to said mechanism and a level control input to said mechanism such that said vacuum force is varied according to an inverse relationship with said rate, and a single manually operated switch operatively connected to said controller, said switch providing an input to said controller over a range that simultaneously adjusts said vacuum force and said rate according to said inverse relationship. (62) Divided out of 519421
Patent NZ-533242-A (NZ)
Title: Oral extended regime contraceptive package
Inventor: BELL ROBERT G
IPC: A61K31/57
Filed: 2002-12-04
Abstract: An extended period contraceptive package includes 81 to 110 dosage forms of estrogen and progestin and 2 to10 dosage forms of just estrogen alone, the dosage forms being arranged in the package in a fixed sequence corresponding to the stages of daily oral administration so as to dictate sequential and continuous daily administration of each of the 81 to 110 dosage forms of estrogen and progestin each day of the 81 to 110 days followed by the sequential and continuous daily administration of each of the 2 to 10 dosage forms of estrogen alone each day for 2 to 10 days.
Patent NZ-538226-A (NZ)
Title: Indoline compounds having an acyl-coenzyme A: cholesterol acyl transferase (ACAT) and lipoperoxidation inhibitory activity and medicinal use thereof
Inventor: KAMIYA SHOUJI
IPC: A61P43/00
Filed: 2003-07-16
Abstract: An indoline compound represented by the general formula (I), a pharmaceutically acceptable salt of the compound; and a medicinal composition containing the indoline compound or pharmaceutically acceptable salt is disclosed, wherein the substituents for the variables are as defined in the specification. These compounds exhibit an excellent acyl-coenzyme A: cholesterol acyl transferase (ACAT) inhibitory activity and lipid peroxidation inhibitory activity and are useful as an ACAT inhibitor or lipid peroxidation inhibitor, hence they are suitable for the prophylaxis or treatment of arteriosclerosis, hyperlipidemia, arteriosclerotic lesion in diabetes, ischemic diseases of brain and heart.
Patent NZ-538995-A (NZ)
Title: Container with snap-on closure
Inventor: MAJOOR FRANCISCUS AUGUSTINUS
IPC: B65D41/48
Filed: 2003-09-25
Abstract: A container suitable for aseptic packing of microbiologically sensitive food products is disclosed. The container has a blow-moulded container body 1 and neck 2 and a snap-on closure 3 that includes a peripheral skirt 4 with a ridge 5, intended for engagement with the inner surface 6 of the neck 2. The free outer diameter of the ridge 5 is slightly larger than the free inner diameter of the neck. The snap-on closure 3 and the neck have means 7, 8 for fixing the ridge in the axial direction of the neck when the container is closed.
Patent NZ-542957-A (NZ)
Title: Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
Inventor: DESTEFANO GEORGE
IPC: A61L9/04
Filed: 2004-03-19
Abstract: The subject of this disclosure is a suspension formulation for use in a metered-dose inhaler (MDI), with the active ingredients being Albuterol Sulphate and Ipratropium Bromide having a hydro-fluoro-alkane (HFA) propellant with a small quantity of added water.
Patent NZ-543612-A (NZ)
Title: Pharmaceutical combination of G-CSF and PLGF useful for blood stem cell
Inventor: GIANNI ALESSANDRO MASSIMO
IPC: A61K38/18
Filed: 2004-07-23
Abstract: Provided is a combined pharmaceutical preparation comprising granulocyte colony-stimulating factor (G-CSF) and placental growth factor (PlGF), useful in the mobilization of blood stem cells in patients. Also provided is a combination of recombinant versions of these two factors. Further provided are uses of the combination in the manufacture of medicaments for conditions of organ or cell transplantation or tumor chemo-radiotherapy.
Patent NZ-544044-A (NZ)
Title: Materials and methods for the modification of plant lignin content
Inventor: BLOKSBERG LEONARD NATHAN
IPC: C12N9/32
Filed: 1999-10-06
Abstract: An isolated polynucleotide encoding cinnamate 4-hydroxylase (C4H), isolated primers for amplifying said polynucleotide, transformed cells transformed by a genetic construct comprising the polynucleotide, and a protein encoded by the polynucleotide are disclosed. Plant lignin content, lignin composition and lignin structure can be modified by stably incorporating into the genome of a plant the polynucleotide.
Patent NZ-546403-A (NZ)
Title: Putrescible organic waste treatment
Inventor: MANCUSO NOEL ANTHONY MARK
IPC: B02C25/00
Filed: 2004-10-22
Abstract: A putrescible organic waste treatment system is disclosed. The putrescible organic waste treatment system comprises: (a) a comminution unit which includes a comminution means adapted to comminute putrescible organic waste, and to mix the comminuted waste with water to form a pulp slurry, where the comminution unit is adapted to be connected to a supply of water; (b) water flowrate control means adapted to vary the flow rate and/or volume of water supplied to the comminution unit; (c) waste assessment means adapted to assess a characteristic of the waste; and (d) a control means in communication with the waste assessment means, and adapted to control the water flow rate control means, where during comminution, the control means controls the quantity of water supplied to the comminution means so that a waste pulp having a predetermined physical characteristic is produced.
Patent NZ-548790-A (NZ)
Title: Fabric reinforced cement
Inventor: ROYER JOSEPH R
IPC: D02G3/44
Filed: 2005-02-25
Abstract: Cementitious articles that are reinforced with a fabric made at least partially of high modulus polyolefin monofilament fibers are disclosed. There is at least one fabric layer having warp and weft yarns. Some of the yarns have a 3% secant modulus of elasticity of at least 100g/denier. The high modulus polypropylene fabric has an intrinsic resistance to the alkaline conditions present in a cementitious composite, as well as a low elongation at break. The high modulus polypropylene may contain a nucleating agent to facilitate the process of obtaining desired draw ratio.
Patent NZ-552647-A (NZ)
Title: Wax-biocide wood treatment
Inventor: ASHMORE JOHN WILLIAM
Filed: 2007-01-16
Abstract: Disclosed is a method for preserving wood; said method comprising contacting wood with an aqueous composition comprising: a) a paraffin wax having a melting point from 45 to 75 degrees Celsius, and an average particle size no greater than 120 nm; b) at least one non-ionic surfactant; and c) at least one organic wood preservative.
Patent NZ-561655-A (NZ)
Title: Methods for treating immune disorders associated with graft transplantation with soluable CTLA4 mutant molecules
Inventor: HAGERTY DAVID
IPC: A61K38/17
Filed: 2006-04-05
Abstract: Provided is the use of a CTLA4 mutant molecule comprising a specified extracellular domain of CTLA4 beginning with alanine at position 26 or methionine at position 27 and ending with aspartic acid at position 150, or a functional portion thereof, wherein in the extracellular domain or functional portion thereof an alanine at position 55 is substituted with a tyrosine, and a leucine at position 130 is substituted with a glutamic acid, in the manufacture of a medicament for treating an immune disorder associated with graft transplantation, wherein the medicament is for administration as an early phase regimen, wherein the early phase regimen ranges from the first 3 to 6 months post-transplantation and involves administration on post-transplantation day 1, week 2, week 4, week 8 and week 12, and involves administration of an effective dose of the CTLA4 mutant molecule to a subject so as to provide for a serum trough concentration of the CTLA4 mutant molecule between about 5 microgram/ml and about 20 microgram/ml during the early phase regimen, and wherein the administration regimen further comprises a maintenance phase regimen wherein the maintenance phase regimen begins after the early phase regimen ends and involves administration of CTLA4 mutant molecule that is not more frequent than monthly and wherein the maintenance phase regimen comprises a serum trough concentration of the CTLA4 mutant molecule between 0.2 microgram/ml to 3 microgram/ml.
Patent NZ-564218-A (NZ)
Title: Method of detoxication of yperite by using haloalkane dehalogenases
Inventor: PROKOP ZBYNEK
IPC: A62D3/02
Filed: 2006-06-01
Abstract: Provided is a method of detoxication of yperite by the use of haloalkane dehalogenases wherein said yperite is treated with at least one haloalkane dehalogenase selected from the group of enzymes EC 3.8.1.5, at the concentration of enzyme 1x10-6 to 1x100 moll-1 , at temperature from +10 degrees C to +70 degrees C and pH from 4 to 12 in liquid medium.
Patent NZ-566615-A (NZ)
Title: Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one having neuroleptic activity
Inventor: COLON-CRUZ ROBERTO
IPC: A61K31/428
Filed: 2003-10-13
Abstract: A process for preparing acyl derivatives of formula (I) as prodrugs of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl-6-chloro-1,3-dihydro-2H-indol-2-one (commonly known as ziprasidone) and pharmaceutically acceptable acid addition salts is disclosed. These compounds have neuroleptic activity and are therefore useful as antipsychotics. (62) (62) Divided Out of 538807
Patent NZ-576593-A (NZ)
Title: Process for the sulfinylation of a pyrazole derivative
Inventor: SUKOPP MARTIN
IPC: C07D231/44
Filed: 2007-11-05
Abstract: Disclosed is a process for the sulfinylation of a pyrazole derivative, characterized in that 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-1 H-pyrazole-3-carbonitrile is reacted with a sulfinylating agent S in the presence of at least one amine acid complex wherein the amine(s) are selected from cyclic secondary amines selected from piperidine, 2-methylpiperidine, 4-methylpiperidine, pyrrolidine, 2-methylpyrrolidine, 3-methylpyrrolidine, imidazolidine, pyrrole, piperazine, and morpholine, and the acid(s) are selected from p-toluenesulfonic acid, benzenesulfonic acid, 4-ethyl benzenesulfonic acid, 4-chlorobenzenesulfonic acid, xylenesulfonic acid, 2,3-dimethylbenzene sulfonic acid, 2,4:"dimethylbenzene sulfonic acid, 2,5-dimethylbenzene sulfonic acid, 2,6-dimethylbenzene sulfonic acid, 1-napthalenesulfonic acid, 2-napthalenesulfonic acid, mixtures of two or more of the isomers of dimethylbenzene sulfonic acid, mesitylene sulfonic acid, methane-sulfonic acid, camphor sulfonic acid, and trifluoromethylsulfonic acid, and with the addition of a halogenating agent, wherein S is [CF3S(O)]2O; or CF3S(O)X wherein X means fluoro, chloro, bromo, iodo, a hydroxy group, or an alkaline or alkaline earth metal salt of the hydroxy group; or mixtures thereof. Also disclosed is a method of treating animals against infestation or infection by parasites or protecting growing plants from infestation from insects, acarids or nematodes by applying or ingesting a 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)-pyrazole-3-carbonitrile prepared by the above process.
Patent NZ-578819-A (NZ)
Title: Treatment of inflammatory diseases using placental stem cells
Inventor: EDINGER JAMES W
IPC: A61K35/644
Filed: 2008-02-12
Abstract: Provided is the use of a therapeutically effective amount of placental stem cells in the manufacture of a medicament for treating an individual having scleroderma, mycosis fungoides, or inflammatory bowel disease, wherein said placental stem cells are (i) CD10+, CD34-, CD105+, and CD200+, or (ii) CD200+ and HLA-G+, or (iii) CD73+, CD105+, and CD200+, or (iv) CD200+ and Oct-4+, and wherein said placental stem cells do not comprise human totipotent stem cells.